Make your appointment or second opinion with Dana-Farber today to meet with an onsite specialist.

Adult Patients:877-442-3324

Pediatric Patients:888-733-4662

Make Appointment OnlineInternational Patients

Online second opinions

Can’t get to Boston? Explore our Online Second Opinion service to get expert advice from Dana-Farber oncologists.

Request a second opinion

Contact & Directions

Email Dana-Farber

Main Number617-632-3000

Toll-Free Number866-408-DFCI (3324)

Maps & DirectionsContact InformationSend us a Question or Comment

How to Help

Discover the ways to give and how to get involved to support Dana-Farber.

Learn More
Give now

  • Waldenström's Macroglobulinemia

    Dana-Farber/Brigham and Women's Cancer Care

    Waldenström's Macroglobulinemia

    The Bing Center for Waldenström’s Macroglobulinemia at Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) brings together a dedicated team of laboratory and clinical-based investigators and physicians who are striving to find more effective therapies for Waldenström’s macroglobulinemia and, someday, a cure.

    We swiftly take discoveries made in our laboratory to the clinic, where new therapies directly benefit our patients.

    Our experts concentrate exclusively on patients with Waldenström’s macroglobulinemia (Waldenström’s) and related immunoglobulin M (IgM) disorders. We offer an extensive array of treatment options, including chemotherapy, targeted therapies, clinical trials, and the full range of support services from a top-ranked hospital and leading cancer research center.

    The Center is part of the Center for Hematologic Oncology, which includes the hematopoietic stem cell transplantation program — one of the largest and most experienced in the world.

    Exceptional Care for Patients with Waldenström's Macroglobulinemia

    • The largest referral center for Waldenström's macroglobulinemia in the world
    • A highly specialized center focusing exclusively on Waldenström's diagnostics, treatment planning, therapy, and research.
    • Genomic-based treatment options.
    • Carefully considered approach that does not always include immediate treatment.
    • Care plans tailored to the needs of each patient, from the first meeting through subsequent treatments in the years to come.
    • Consultations and second opinions for patients and physicians around the world.
    • Pioneering research in genomic sequencing and related treatments that is setting the standard of care for this disease around the world.
    • Physician-scientists who are not only part of the care team, but who also work in our labs to develop drugs that target the genetic drivers of Waldenström's, bringing new and more effective treatments to patients quickly.
    • Our specialists establish guidelines for workup, diagnosis, prognosis, response, and treatment. Our experts are part of every international committee on Waldenström's.
    • A treatment plan developed by a multidisciplinary team that works closely together to ensure that every approach is considered.

    We Treat You, Not Just Your Cancer

    Our entire team is here to support you throughout treatment and during recovery. You and your family have access to our full range of support services.

    Next: About Waldenström's Macroglobulinemia

  •   Email
  •   Print
  •   Share
  • Make an Appointment

    • New adult histiocytosis patients:
      617-632-6246 or 617-632-5138
    • Make Appointment Online
  • Highest ranked in New England

  • How Our Blood Cancer Patients Rate Dana-Farber

  • Waldenström's online community

    • Join the Dana-Farber Waldenström's Macroglobulinemia community on CancerConnect for support and information from others affected by this disease.
  • Online Resource for Precision Cancer Medicine

    • Clinicians at Dana-Farber/
      Brigham and Women's Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine for certain types of blood cancers and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.